# The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy

> **NCT01266629** · — · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01266629
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266629, "The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01266629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*